< Zurück zu den aktuellen Neuigkeiten & Events

Neuigkeiten

Oral Proceedings before EPO Opposition Divisions – VC mandatory from January 2021 – will the Board of Appeal follow?

November 2020

On 10 November 2020 the EPO announced further measures in relation to the Pilot Project to allow opposition hearings to be held by videoconference (VC). Initially, the pilot project was to finish by April 2021. By a Decision of the President, this has now been extended until September 2021.

The full details of the how VC will work in the content of opposition oral proceedings can be found in the Decision of the President of the European Patent Office dated 10 November 2020 concerning the modification and extension of the pilot project for oral proceedings by videoconference before opposition divisions. The key points of the Decision to note are in Article 2:

  1. Oral proceedings before opposition divisions are held by videoconference.
  2. Notwithstanding paragraph 1, oral proceedings may be held on the premises of the European Patent Office, either at the request of a party or at the instigation of the opposition division if there are serious reasons against holding the oral proceedings by videoconference. If a request to hold oral proceedings on the premises of the European Patent Office is refused, the parties will be informed of the reasons; such a refusal is not separately appealable.
  3. Oral proceedings by videoconference are equivalent to oral proceedings held on the premises of the European Patent Office.

Accordingly, from 04 January 2021 it should be expected that the default position will be that Opposition oral proceedings will take place by videoconference.

As the current scheme allows one party to veto videoconference oral proceedings this is an unsurprising change given the increase in the backlog of cases that has built up over the past eight months. Indeed, the EPO has reported that uptake rate of the current “voluntary” scheme for VC oral proceedings has remained low whilst the backlog of unresolved opposition cases has built up with a “resulting loss in timeliness which is critical for access to justice”.

The parties to oral proceedings affected by the new measures will be informed by the EPO.

Regarding the Boards of Appeal, we understand that the President of the Boards of Appeal will soon launch a consultation concerning an amendment to its Rules of Procedure (RPBA) whereby a new rule (15A) will be introduced. The new rule allows a Board of Appeal to compel oral proceedings by videoconference, the draft text of which is as follows:

  1. The Board may decide to hold oral proceedings pursuant to A.116 EPC by videoconference if the Board considers it appropriate to do so, either upon request by a party or of its own motion.
  2. If oral proceedings are to be held by videoconference pursuant to paragraph (1), the Chair may order a party, representative or accompanying person to attend only remotely. The Chair may allow any member of he Board in the particular appeal to participate remotely. Any access to the videoconference shall be provided in real time.

According to some draft notes seen by HGF, examples of ‘appropriateness’ include (i) the suitability of the case, notably its complexity or the need for interpretation, (ii) the parties’ willingness to attend remotely, (iii) foreseeable travel restrictions and (iv) personal circumstances of the persons due to be involved. Markedly, the notes to A.15A(2) foresee an asymmetry in representation, whereby one party is present at the hearing and another party accesses the Hearing remotely.

The draft timetable for amendment of the RPBA is 01 April 2021 but it is said that Boards ‘may change their practice before that date’. Accordingly, HGF expect that the Boards will apply increased pressure on parties to conduct hearings by videoconference, especially if travel restrictions due to the pandemic continue.

This article was prepared by HGF Partner Dr Chris Moore. If you would like further advice on this or any other matter, please contact Chris. Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Aktuelle Neuigkeiten

HGF Director Promotions

We are pleased to announce a number of director promotions that will take effect from 1st December 2025. These individuals have demonstrated exceptional expertise, commitment, and leadership within their respective …

Weiterlesen

UK IPO fees to increase from 1 April 2026

Whilst the fee changes are subject to parliamentary approval, they are almost certain to take effect – read on to learn more. The United Kingdom Intellectual Property Office (UK IPO) …

Weiterlesen

Mycelium Meets Market Reality: The Quiet Role of IP in Scaling Sustainable Materials

Fungal materials are increasingly used in applications ranging from sustainable packaging and leather alternatives to construction composites, textiles, and biotechnology. These developments are transforming fungi from a niche research subject …

Weiterlesen
Event - 24. bis 25. November 2025

HGF Partners with 3AF for the P2I2025 Symposium

HGF are pleased to be a partner of P2I2025, the annual symposium organised by the Intellectual Property Commission of the French Aeronautics and Astronautics Association (3AF). The event brings together …

Veranstaltungsdetails

Retailers liability and AI Applications

The question of whether the user (consumer) or the provider of an AI application is liable for the infringement of intellectual property rights as a result of the use of …

Weiterlesen
Event - 11. November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Veranstaltungsdetails

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Weiterlesen

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Weiterlesen